Goiânia reforça vacinação contra meningite após 35 casos e 11 mortes em 2025

35 confirmed meningitis cases and 11 deaths in Goiânia during 2025, with 13 cases and 5 deaths already recorded in 2026, primarily affecting children.
Each unvaccinated child represents a potential case
Health officials warn that gaps in vaccination coverage are creating conditions for the disease to spread.

Em Goiânia, a meningite avança com uma velocidade que desafia a indiferença: 11 mortes em 2025 e cinco já em 2026 revelam não apenas a brutalidade da doença, mas uma lacuna coletiva na proteção que a ciência já oferece. A cobertura vacinal abaixo da meta recomendada transforma uma ameaça evitável em tragédia recorrente, sobretudo entre as crianças. As autoridades de saúde reforçam que as ferramentas de prevenção existem, são gratuitas e estão disponíveis — o que falta é a decisão de usá-las antes que a doença chegue primeiro.

  • Goiânia registra um ritmo crescente de mortes por meningite: 11 óbitos em 2025 e já cinco em 2026, com crianças entre as principais vítimas.
  • A cobertura vacinal da cidade permanece perigosamente abaixo dos 95% recomendados, criando brechas por onde a bactéria circula livremente.
  • A doença age com rapidez brutal — febre súbita, rigidez de nuca, manchas na pele e confusão mental podem evoluir para morte ou sequelas permanentes em horas.
  • A Secretaria Municipal de Saúde intensificou o alerta público e convoca pais e responsáveis a atualizar o cartão vacinal das crianças e adolescentes.
  • Todas as vacinas contra as principais formas bacterianas de meningite estão disponíveis gratuitamente nas unidades de saúde de Goiânia, sem necessidade de agendamento especial.

Goiânia enfrenta um surto de meningite que se agrava a cada mês. Em 2025, foram 35 casos confirmados e 11 mortes. Em 2026, com o ano ainda em curso, já são 13 casos e cinco óbitos — números que levaram a Secretaria Municipal de Saúde a intensificar o alerta à população.

O secretário Luiz Pellizzer aponta a baixa cobertura vacinal como o nó central do problema. A vacina Meningocócica C atingiu apenas 84,10% da população-alvo, enquanto a Pentavalente chegou a 86,35% — ambas aquém dos 95% considerados necessários pelo Ministério da Saúde para interromper a circulação da doença. Essa lacuna, segundo ele, é o que permite ao agente infeccioso encontrar caminhos, especialmente entre as crianças.

A meningite é uma doença que não dá margem à demora. Ela inflama as membranas que envolvem o cérebro e a medula espinhal e pode ser causada por vírus, bactérias, fungos ou parasitas. Seus sinais — febre alta repentina, dor de cabeça intensa, rigidez de nuca, vômitos e manchas avermelhadas ou arroxeadas na pele — exigem atenção imediata. Em bebês, os sintomas podem se manifestar como irritabilidade extrema ou abaulamento da fontanela.

A proteção, no entanto, existe e é gratuita. O SUS oferece vacinas contra as principais formas bacterianas da doença, incluindo BCG, Pentavalente, Pneumocócica 10, Meningocócica C e ACWY — esta última voltada a adolescentes entre 11 e 14 anos, com reforço ao primeiro ano de vida. O recado das autoridades é direto: levar as crianças às unidades de saúde e atualizar o cartão de vacinação. A janela para conter o surto ainda está aberta — mas cada dia sem vacinação é um risco que não precisa ser corrido.

Goiânia is in the grip of a meningitis outbreak that has claimed lives at an accelerating pace. Last year, the city recorded 35 confirmed cases and 11 deaths from the disease. This year, with months still remaining, the count has already reached 13 cases and five deaths—a trajectory that has alarmed public health officials enough to launch a renewed push for vaccination.

The Municipal Health Secretary, Luiz Pellizzer, has made clear what he sees as the root problem: vaccination coverage across the city remains stubbornly below the targets set by Brazil's Health Ministry. The Meningococcal C vaccine has reached only 84.10 percent coverage, while the five-dose Pentavalent combination sits at 86.35 percent. Both fall short of the 95 percent threshold the ministry considers necessary to prevent sustained disease circulation. That gap, Pellizzer argues, is creating conditions for the virus to spread, particularly among children, who face the most severe consequences.

Meningitis itself is a disease that moves fast and strikes hard. It causes inflammation of the membranes surrounding the brain and spinal cord, and it can be triggered by viruses, bacteria, fungi, or parasites. The warning signs are unmistakable: sudden high fever, severe headache, vomiting, a stiff neck, drowsiness, and a distinctive rash of red or purple spots across the skin. In infants, the disease may announce itself differently—through unusual irritability or a bulging soft spot on the skull—but the urgency is the same.

The good news, health authorities emphasize, is that protection is available and free. The public health system offers several vaccines that guard against the main bacterial forms of meningitis: the BCG, Pentavalent, Pneumococcal 10, Meningococcal C, and ACWY vaccines. The ACWY vaccine is specifically designed for adolescents between 11 and 14 years old and protects against four different strains of the disease, with a booster dose given at age one. All of these are available at no cost in health clinics throughout Goiânia.

Pellizzer's message to parents and guardians is straightforward: bring your children to a vaccination clinic and update their immunization records. The window to prevent this outbreak from worsening remains open, but it will not stay that way indefinitely. Each unvaccinated child represents a potential case, and each case carries the risk of permanent disability or death. The city's health system has the tools. What it needs now is for families to use them.

We still have important vaccines below the target recommended by the Health Ministry. This increases the risk of disease circulation and severe cases, especially among children.
— Luiz Pellizzer, Municipal Health Secretary of Goiânia
The Hearth Conversation Another angle on the story
Inventor

Why is Goiânia seeing this surge now, in 2026, when vaccination has been available for years?

Model

The coverage numbers tell the story—84 percent is not the same as 95 percent. That five to ten percent gap might sound small, but in a city of over a million people, it means tens of thousands of unvaccinated children. All it takes is one case to spread to a cluster, and a cluster to become an outbreak.

Inventor

Are there neighborhoods or populations being hit harder than others?

Model

The source doesn't specify, but the health secretary's emphasis on children suggests they're the most vulnerable. Younger kids have less developed immune systems, and infants can't receive all the vaccines yet. That's why the push is so urgent.

Inventor

What happens to someone who survives meningitis?

Model

The source focuses on prevention, not aftermath, but meningitis survivors often face lasting damage—hearing loss, brain injury, limb amputation in severe cases. That's part of why the health secretary is so direct about the stakes.

Inventor

Is this a resource problem, or a trust problem?

Model

The vaccines are free and available. So it's not access in the traditional sense. It could be awareness, hesitation, or simply the friction of getting to a clinic. But the health secretary is framing it as a choice—parents need to make the decision to protect their children.

Inventor

What does 95 percent coverage actually mean in practice?

Model

It's the threshold where disease transmission slows dramatically. Below that, you get pockets of vulnerability. The virus finds those pockets and takes hold. Goiânia is learning that lesson in real time.

Contact Us FAQ